Molly Bowen

CRS:

BJMC

Role:

Communications

Position:

Communications Associate

Email:

molly.bowen@jhmi.edu

Phone:

410-955-9948

Molly Bowen is Communications Associate at the Johns Hopkins Center for Clinical Global Health Education (CCGHE). She establishes and maintains systems for information management, and devises strategies, develops content, and manages production and workflow for organizational reporting, donor relations, media outreach, marketing and promotional materials, and the CCGHE website. She also is charged with communications for the Baltimore-Washington-India Clinical Trials Unit.

Prior to joining CCGHE in March 2015, Molly worked for more than 15 years with Dr. D.A. Henderson, first joining the Johns Hopkins Center for Civilian Biodefense Studies in 1999, and moving with the group in 2003 to found the UPMC Center for Health Security. As the first non-faculty member hired, Molly established administrative, finance, and communications functions for the organization, and served for 10 years as Senior Communications Specialist. Prior to that position, she worked for 9 years with ORBIS Associates, non-profit American Indian owned and managed educational consulting firm in Washington, DC.

She has a BA in American Studies from Keene State College, Keene, New Hampshire.

Categories

Leadership Committees
CRS
Roles

Clinical Trials

HPTN083: A Phase 2b/3 Double Blind Safety and Efficacy Study...

HPTN 083 is a study being done to evaluate the efficacy of the long-acting injectable agent, cabotegravir (CAB LA), for...

Read More

A5349: Rifapentine-containing treatment shortening regimens...

The purpose of this study is to determine whether one or two four-month regimens of tuberculosis treatment are as effective as a...

Read More

A5308: A Prospective, Single-Arm, Open-Label Study to...

This study is being done with people who are infected with HIV, but do not show any signs of having HIV. They are also feeling...

Read More

HPTN 069: A Phase II Randomized, Double-Blind, Study of the...

HPTN 069 is a phase II, four-arm, multisite, randomized, double-blinded trial. To assess the safety and tolerability of four...

Read More

P1073: Study of Immune Reconstitution Inflammatory Syndrome...

P1073 is a case controlled prospective, clinical, observational and pathogenesis study of HIV-infected infants and children...

Read More